Get 20% Free Customization In This Report

Buy this report from - $3456

Animal Vaccines Market by Product Type (Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, and DNA Vaccines) and Animal Type [Companion animals (Dogs, Cats, and Others), Cattle, Pigs, Poultry, and Sheep] - Global Opportunity Analysis and Industry Forecast, 2014-2022

Pharmaceuticals	LI_171988	Pages: 160	Mar 2017 \| 2698 Views
Author's : Onkar Sumant	Tables: 51	Charts: 49	Formats*:

Animal Vaccines Market Overview:

Global Animal Vaccines Market is expected to garner $9,159 million, registering a CAGR of 5.2% during the forecast period, 2016-2022. Animal vaccines control the transmission diseases, thus providing protection to animal and human health. Animals serve as an important source of food, meat, milk, protein, and other commercial products, such as leather and wool. Most commonly used veterinary vaccines include rabies vaccines, foot & mouth diseases vaccines, and equine influenza virus vaccines, which prevent the transmission of infectious agents by mimicking the naturally acquired immunity. Constant development of vaccines is essential with rise in emergence of different animal diseases. Increase in pet ownership has significantly accelerated the market growth.

The animal vaccines market is segmented on the basis of product type, animal type, and geography. By product type, the industry is categorized into attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. Based on animal type, it is classified into companion animals, cattle, pigs, poultry, and sheep. The companion animals segment is sub-segmented into dogs, cats, and others. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The animal vaccines market is growing at a steady pace owing to increase in pet ownership in developed countries and rise in number of cattle & poultry in developing countries. Furthermore, rise in investment for R&D of vaccines, which inhibit the growth of antibiotic-resistant organisms boosts the market growth. For instance, Elanco invested two-thirds of the budget for food animal unit to develop vaccines and reduce the use of antibiotics, in August 2016. Moreover, rise in demand for animal vaccines led to the emergence of multiple new vaccines. For instance, Cevac IBron a new vaccine was launched by Ceva that prevents against infectious bronchitis virus (IBV), in February 2017.

The key players profiled in the animal vaccines market report include Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, and Anicon Labor GmbH.
Other players operating in the market are Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, and Arko Laboratories, Ltd.

Global Animal Vaccines Market Revenue, By Geography

Get more information on this report : Request Sample Pages

Asia-Pacific possesses high market potential for the animal vaccines due to increase in pet ownership and rise in incidence of various zoonotic diseases. Moreover, ongoing research on innovative vaccine production technology has increased due to high demand for animal-based food products and companion animals. In addition, increase in investments in animal healthcare companies has improved the production of innovative vaccines.

Get more information on this report : Request Sample Pages

The animal vaccines market in Saudi Arabia is projected to grow at a CAGR of 7.3% during the forecast period. In addition, the U.S. is a mature market for the animal vaccines, as it holds maximum share in the patent registration for animal vaccines. However, Asia-Pacific is experiencing a fast-paced growth in terms of production and development of animal vaccines.

Get more information on this report : Request Sample Pages

Animal Vaccines Market Report Key Benefits:

It provides an extensive analysis of the current trends and highlights the market potential in terms of value
It offers a comprehensive evaluation of the market scenario with respect to the product type and animal type
It presents assessment of the patents to determine the prevailing opportunities
It includes recent developments, key manufacturers, and shares to analyze the competitive scenario of the market
It offers an in-depth geographical analysis to helps in understanding the regional market, which assists in strategic business planning

Animal Vaccines Market Key Segments:

By Product

Attenuated Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
Conjugate Vaccines
Recombinant Vaccines
DNA Vaccines

By Animal Type

Companion Animals
- Dogs
- Cats
- Others
Cattle
Pigs
Poultry
Sheep

By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Venezuela
- Saudi Arabia
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO Perspective

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets

3.3. GOVERNMENT REGULATIONS

3.3.1. Center for Veterinary Biologics(CVB)

3.4. PATENTS ANALYSIS

3.4.1. PATENT ANALYSIS BY YEAR
3.4.2. PATENT ANALYSIS BY REGION

3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Rising demand for animal derived food products
3.5.1.2. Growing demand for pet insurance
3.5.1.3. Rising concern to prevent zoonotic diseases
3.5.1.4. Growing ownership of companion animals
3.5.1.5. Rising animal health expenditure

3.5.2. Restraints

3.5.2.1. Highly competitive meat and milk prices
3.5.2.2. Lack of animal health awareness
3.5.2.3. Adverse impact of veterinary vaccines on human and animal health

3.5.3. Opportunities

3.5.3.1. Advancement in vaccine products
3.5.3.2. Vaccine products for hybrid animals

Chapter: 4 ANIMAL VACCINES MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. ATTENUATED VACCINES

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. INACTIVATED VACCINES

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. SUBUNIT VACCINES

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

4.5. TOXOID VACCINES

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast

4.6. CONJUGATE VACCINES

4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast

4.7. RECOMBINANT VACCINES

4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast

4.8. DNA VACCINES

4.8.1. Key market trends
4.8.2. Key growth factors and opportunities
4.8.3. Market size and forecast

Chapter: 5 ANIMAL VACCINES MARKET, BY ANIMAL TYPE

5.1. OVERVIEW
5.2. COMPANION ANIMALS

5.2.1. Market size and forecast
5.2.2. Dogs
5.2.3. Cats
5.2.4. Other Companion Animals

5.3. CATTLE

5.3.1. Market size and forecast

5.4. PIGS

5.4.1. Market size and forecast

5.5. POULTRY

5.5.1. Market size and forecast

5.6. SHEEP

5.6.1. Market size and forecast

Chapter: 6 ANIMAL VACCINES MARKET, BY GEOGRAPHY

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S. market size & forecast
6.2.5. Canada market size & forecast
6.2.6. Mexico market size & forecast

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany market size & forecast
6.3.5. France market size & forecast
6.3.6. UK market size & forecast
6.3.7. Italy market size & forecast
6.3.8. Rest of Europe market size and forecast

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan market size & forecast
6.4.5. China market size & forecast
6.4.6. Australia market size & forecast
6.4.7. India market size & forecast
6.4.8. South Korea market size & forecast
6.4.9. Taiwan market size & forecast
6.4.10. Rest of Asia-Pacific market size and forecast

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil market size & forecast
6.5.5. Turkey market size & forecast
6.5.6. Venezuela market size & forecast
6.5.7. Saudi Arabia market size & forecast
6.5.8. Rest of LAMEA market size and forecast

Chapter: 7 COMPANY PROFILES

7.1. MERCK & CO., INC.

7.1.1. Company overview
7.1.2. Operating business segments
7.1.3. Business performance
7.1.4. Key strategic moves & developments

7.2. ZOETIS INC.

7.2.1. Company overview
7.2.2. Operating business segments
7.2.3. Business performance
7.2.4. Key strategic moves & developments

7.3. CEVA SANTÉ ANIMALE

7.3.1. Company overview
7.3.2. Operating business segments
7.3.3. Business performance

7.4. SANOFI S.A.

7.4.1. Company overview
7.4.2. Business performance
7.4.3. Key strategic moves & developments

7.5. ROMVAC

7.5.1. Company overview
7.5.2. Operating business segments
7.5.3. Business performance

7.6. VAXXINOVA

7.6.1. Company overview
7.6.2. Operating business segments
7.6.3. Business performance

7.7. BIOVAC

7.7.1. Company overview
7.7.2. Operating business segments
7.7.3. Business performance
7.7.4. Key strategic moves & developments

7.8. MERIAL

7.8.1. Company overview
7.8.2. Operating business segments
7.8.3. Business performance

7.9. ANICON LABOR GMBH

7.9.1. Company overview
7.9.2. Business performance
7.9.3. Key strategic moves & developments

LIST OF TABLES

TABLE 1. GLOBAL ANIMAL VACCINES MARKET, BY PRODUCT TYPE ($MILLION)
TABLE 2. GLOBAL ATTENUATED ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 3. GLOBAL INACTIVATED ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 4. GLOBAL SUBUNIT ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 5. GLOBAL TOXOID ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 6. GLOBAL CONJUGATE ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 7. GLOBAL RECOMBINANT ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 8. GLOBAL DNA ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 9. GLOBAL ANIMAL VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 10. GLOBAL COMPANION ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 11. GLOBAL ANIMAL VACCINES CATTLE MARKET, BY GEOGRAPHY ($MILLION)
TABLE 12. GLOBAL ANIMAL VACCINES PIGS MARKET, BY GEOGRAPHY ($MILLION)
TABLE 13. GLOBAL ANIMAL VACCINES POULTRY MARKET, BY GEOGRAPHY ($MILLION)
TABLE 14. GLOBAL ANIMAL VACCINES SHEEP MARKET, BY GEOGRAPHY ($MILLION)
TABLE 15. GLOBAL ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 16. NORTH AMERICA ANIMAL VACCINES MARKET, BY PRODUCT ($MILLION)
TABLE 17. NORTH AMERICA VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 18. NORTH AMERICA COMPANION ANIMAL VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 19. NORTH AMERICA ANIMAL VACCINES MARKET, BY COUNTRY ($MILLION)
TABLE 20. EUROPE VACCINES MARKET, BY PRODUCT ($MILLION)
TABLE 21. EUROPE VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 22. EUROPE COMPANION ANIMAL VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 23. EUROPE ANIMAL VACCINES MARKET, BY COUNTRY ($MILLION)
TABLE 24. ASIA-PACIFIC VACCINES MARKET, BY PRODUCT ($MILLION)
TABLE 25. ASIA-PACIFIC VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 26. ASIA-PACIFIC COMPANION ANIMAL VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 27. ASIA-PACIFIC ANIMAL VACCINES MARKET, BY COUNTRY ($MILLION)
TABLE 28. LAMEA VACCINES MARKET, BY PRODUCT ($MILLION)
TABLE 29. LAMEA VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 30. LAMEA COMPANION ANIMAL VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 31. LAMEA ANIMAL VACCINES MARKET, BY COUNTRY ($MILLION)
TABLE 32. ROMVAC: COMPANY SNAPSHOT
TABLE 33. ROMVAC: OPERATING SEGMENTS
TABLE 34. VAXXINOVA: COMPANY SNAPSHOT
TABLE 35. VAXXINOVA: OPERATING SEGMENTS
TABLE 36. BIOVAC: COMPANY SNAPSHOT
TABLE 37. BIOVAC: OPERATING SEGMENTS
TABLE 38. MERCK: COMPANY SNAPSHOT
TABLE 39. MERCK: OPERATING SEGMENTS
TABLE 40. ZOETIS: COMPANY SNAPSHOT
TABLE 41. ZOETIS: OPERATING SEGMENTS
TABLE 42. CEVA SANTÉ ANIMALE: COMPANY SNAPSHOT
TABLE 43. CEVA SANTÉ ANIMALE: OPERATING SEGMENTS
TABLE 44. SANOFI: COMPANY SNAPSHOT
TABLE 45. SANOFI: OPERATING SEGMENTS
TABLE 46. MERIAL: COMPANY SNAPSHOT
TABLE 47. MERIAL: OPERATING SEGMENTS
TABLE 48. ANICON LABOR GMBH: COMPANY SNAPSHOT
TABLE 49. ANICON LABOR GMBH: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. GLOBAL ANIMAL VACCINES MARKET: SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS: GLOBAL ANIMAL VACCINES MARKET, BY ANIMAL TYPE
FIGURE 3. U.S. ANIMAL VACCINES MARKET, 2014-2022
FIGURE 4. CANADA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 5. MEXICO ANIMAL VACCINES MARKET, 2014-2022
FIGURE 6. GERMANY ANIMAL VACCINES MARKET, 2014-2022
FIGURE 7. FRANCE ANIMAL VACCINES MARKET, 2014-2022
FIGURE 8. UK ANIMAL VACCINES MARKET, 2014-2022
FIGURE 9. ITALY ANIMAL VACCINES MARKET, 2014-2022
FIGURE 10. REST OF EUROPE ANIMAL VACCINES MARKET, 2014-2022
FIGURE 11. JAPAN ANIMAL VACCINES MARKET, 2014-2022
FIGURE 12. CHINA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 13. AUSTRALIA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 14. INDIA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 15. SOUTH KOREA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 16. TAIWAN ANIMAL VACCINES MARKET, 2014-2022
FIGURE 17. REST OF ASIA-PACIFIC ANIMAL VACCINES MARKET, 2014-2022
FIGURE 18. BRAZIL ANIMAL VACCINES MARKET, 2014-2022
FIGURE 19. TURKEY ANIMAL VACCINES MARKET, 2014-2022
FIGURE 20. VENEZEULA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 21. SAUDI ARABIA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 22. LAMEA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 23. ROMVAC: REVENUE, BY YEAR ($MILLION)
FIGURE 24. ROMVAC: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 25. ROMVAC: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 26. VAXXINOVA: REVENUE, BY YEAR ($MILLION)
FIGURE 27. VAXXINOVA: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 28. VAXXINOVA: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 29. BIOVAC: REVENUE, BY YEAR ($MILLION)
FIGURE 30. BIOVAC: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 31. BIOVAC: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 32. MERCK: REVENUE, BY YEAR ($MILLION)
FIGURE 33. MERCK: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 34. MERCK: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 35. ZOETIS: REVENUE, BY YEAR ($MILLION)
FIGURE 36. ZOETIS: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 37. ZOETIS: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 38. CEVA SANTÉ ANIMALE: REVENUE, BY YEAR ($MILLION)
FIGURE 39. CEVA SANTÉ ANIMALE: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 40. CEVA SANTÉ ANIMALE: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 41. SANOFI: REVENUE, BY YEAR ($MILLION)
FIGURE 42. SANOFI: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 43. SANOFI: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 44. MERIAL: REVENUE, BY YEAR ($MILLION)
FIGURE 45. MERIAL: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 46. MERIAL: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 47. ANICON LABOR GMBH: REVENUE, BY YEAR ($MILLION)
FIGURE 48. ANICON LABOR GMBH: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 49. ANICON LABOR GMBH: REVENUE, BY GEOGRAPHY, 2015 (%)

The animal vaccines market is expected to witness moderate growth owing to increase in incidence of various animal diseases such as rabies and Newcastle disease. The demand for animal vaccines is anticipated to increase owing to high nutritional value of animal-derived food products such as meat & milk and rise in need for companion animals. Furthermore, rise in emergence of antibiotic-resistant microorganisms due to high usage of antibiotics among animals is expected to fuel the growth of the global animal vaccines market.

Advancement in production of vaccines is expected to have a positive impact on the market growth. The advancement in the field of molecular biology has increased the production of DNA & recombinant vaccines. Advancement in production of plant-based animal vaccines reduces the production cost and makes the vaccines safer and more stable for usage in animals.

The employment of technologically advanced animal vaccines is highest in North America, owing of the increase in adoption of these products and rise in disposable income. The growth of the market is driven by rise in disposable income, increase in demand for meat in developing countries such as China and India, and growth in adoption of companion animals. The cattle segment significantly contributes toward the market growth owing to the rise in demand for dairy products.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Animal Vaccines Market Overview: